Evidence map›Paper›PMID 28811329›Full record

ArticleCancer research2017

Transglutaminase 2 Is a Direct Target Gene of YAP-TAZ-Response.

Matthew L Fisher, Gautam Adhikary, Candace Kerr, Daniel Grun, Richard L Eckert

Erratum issuedAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. The Role of Transglutaminase 2 in Cancer: An Update.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Matthew L FisherDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.
Gautam AdhikaryDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.
Candace KerrDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.
Daniel GrunDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.
Richard L EckertDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland. reckert@umaryland.edu.

Funding

Polycomb proteins and skin cancer preventionR01CA131074 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ECKERT, RICHARD L. · 2008 to 2017
$4.6M
Stem Cells and Skin Cancer Prevention and AngiogenesisR01CA184027 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ECKERT, RICHARD L. · 2015 to 2019
$1.9M
NCI NIH HHS R01 CA131074NCI NIH HHS R01 CA184027
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GTP-Binding ProteinsAdaptor Proteins, Signal TransducingHumansPhosphoproteinsProtein Glutamine gamma Glutamyltransferase 2TransglutaminasesAdaptor Proteins, Signal TransducingGTP-Binding ProteinsPhosphoproteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminases

Identifiers

PMID28811329
PMCPMC5675038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.